“…In detail, the new BioFire FilmArray BCID2 panel analyzes a total of 43 targets associated with BSI, including 15 Gram-negative bacteria, 11 Gram-positive bacteria, 7 yeast species, and 10 antimicrobial resistance genes including those encoding carbapenemases (IMP, KPC, OXA-48-like, NDM, and VIM), and CTX-M-type extended-spectrum β-lactamases (ESBLs), as well as those responsible for colistin resistance ( mcr-1 ), methicillin resistance ( mecA/C, and specifically for methicillin-resistant Staphylococcus aureus —MRSA, mecA/C and MREJ— mec right-extremity junction) and vancomycin resistance ( vanA/B ) [ 8 ]. Unlike BCID, only a few published studies are available in the literature to validate and support BCID2 panel potential functioning and implementation in BSI routine workflows [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ].…”